Sana Biotechnology (SANA) Interest Coverage Ratio (2020 - 2026)
Sana Biotechnology (SANA) posted Interest Coverage Ratio of 0.43 for Q1 2026, up 100.0% sequentially from 61199.0 in Q4 2025, and down 40.42% YoY from 0.72 in Q1 2025.
Sana Biotechnology (SANA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Interest Coverage Ratio for 7 years, with the latest figure at 0.43 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 40.42% year-over-year to 0.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.18 (down 70.78% YoY) and the FY2025 annual result came in at 2.1, up 40.33% from the prior year.
- Interest Coverage Ratio grew to 0.43 in Q1 2026 per SANA's latest filing, from 61199.0 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.01 in Q3 2023 and troughed at 61199.0 in Q4 2025.
- A 5-year average of 3603.74 and a median of 0.59 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio soared 98.98% in 2023, then slumped 177363.38% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 22.04 in 2022, then jumped by 98.98% to 0.23 in 2023, then tumbled by 15223.35% to 34.49 in 2024, then plunged by 177363.38% to 61199.0 in 2025, then soared by 100.0% to 0.43 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.43, 61199.0, and 1.02 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Sana Biotechnology | 1.06 Bn | 1.06 Bn | - | -0.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.59 |
| Mar 31, 2026 | -0.43 |
| Dec 31, 2025 | -61,199.00 |
| Sep 30, 2025 | -1.02 |
| Jun 30, 2025 | -0.73 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | -34.49 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -0.59 |
| Mar 31, 2024 | -1.29 |
| Dec 31, 2023 | -0.23 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -0.79 |
| Dec 31, 2022 | -22.04 |
| Sep 30, 2022 | -0.56 |
| Jun 30, 2022 | -1.06 |
| Mar 31, 2022 | -0.18 |
| Dec 31, 2021 | -0.71 |
| Sep 30, 2021 | -0.49 |